KPIs & Operating Metrics(New)

Assets By Segment Breakdown Of Assets Contractual Obligations Annual Cost Of Sales Employee Statistics Gross Margin %Gross Profit Income Before Income Tax International Revenue Breakdown Med Surg And Neurotechnolgy Revenue By Geography Medsurg And Neurotechnology Revenue By Geography Annual Med Surg Revenue By Category Med Surg Revenue By Category Annual Med Surg Revenue By Geography Annual (Deprecated)Med Surg Revenue By Geography (Deprecated)Neurotechnology And Spine Revenue By Category Annual Neurotechnology And Spine Revenue By Category (Deprecated)Neurotechnology And Spine Revenue By Geography Annual (Deprecated)Neurotechnology And Spine Revenue By Geography (Deprecated)Non Gaap Profitability Non Gaap Profitability %Non Gaap Profitability Annual Non Gaap Profitability Annual %Operating Income By Segment Operating Income By Segment Annual Operating Margin By Segment %Operating Margin By Segment Annual %OPEX As A% Of Total Revenue %OPEX Segregation Orthopaedics And Spine Revenue By Geography Orthopaedics And Spine Revenue By Geography Annual Orthopaedics Revenue By Category Orthopaedics Revenue By Category Annual Orthopaedics Revenue By Geography Annual (Deprecated)Orthopaedics Revenue By Geography (Deprecated)Property, Plant And Equipment, Net Breakdown Property, Plant And Equipment, Net By Geography Revenue By Geography Revenue By Geography %Revenue By Geography Annual Revenue By Geography Annual %Revenue By Product Revenue By Product %Revenue By Product Annual Revenue By Product Annual %

Balance Sheet

Cash Flow Statement

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Stryker (SYK) Gross Profit (2016 - 2025)

Stryker has reported Gross Profit over the past 18 years, most recently at $3.8 billion for Q1 2026.

Quarterly Gross Profit rose 1.76% to $3.8 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $16.1 billion through Mar 2026, up 8.62% year-over-year, with the annual reading at $16.1 billion for FY2025, 11.25% up from the prior year.
Gross Profit was $3.8 billion for Q1 2026 at Stryker, down from $4.6 billion in the prior quarter.
Over five years, Gross Profit peaked at $4.6 billion in Q4 2025 and troughed at $2.7 billion in Q1 2022.
The 5-year median for Gross Profit is $3.4 billion (2024), against an average of $3.5 billion.
Year-over-year, Gross Profit increased 14.43% in 2023 and then grew 1.76% in 2026.
A 5-year view of Gross Profit shows it stood at $3.2 billion in 2022, then increased by 14.43% to $3.7 billion in 2023, then increased by 12.72% to $4.2 billion in 2024, then rose by 10.88% to $4.6 billion in 2025, then dropped by 17.68% to $3.8 billion in 2026.
Per Business Quant, the three most recent readings for SYK's Gross Profit are $3.8 billion (Q1 2026), $4.6 billion (Q4 2025), and $3.9 billion (Q3 2025).